{"version":1,"type":"rich","provider_name":"Libsyn","provider_url":"https:\/\/www.libsyn.com","height":300,"width":600,"title":"Dapagliflozin Before the Cardiac Surgery: Kidney Protection in Four Doses","description":"\ud83e\udec0\ud83d\udc8a Can 4 doses help protect the kidney after cardiac surgery? MERCURI-2 randomized 784 patients to perioperative dapagliflozin or placebo. AKI within 7 days fell from 52% to 28%\u2014RR 0.54, an absolute reduction of ~24% and NNT \u22484. \ud83d\udcc9 Intriguingly, the signal was driven largely by urine-output\u2013defined AKI; creatinine-only AKI was unchanged. Hard 30-day outcomes were also unchanged. \ud83c\udf99\ufe0f A provocative new chapter in perioperative cardiorenal protection. \ud83d\udee1\ufe0f ","author_name":"Dr. RR Baliga's 'Podkast for the Kurious Doc'. Where Curiosity meets Clarity!","author_url":"http:\/\/www.MasterMedFacts.com","html":"<iframe title=\"Libsyn Player\" style=\"border: none\" src=\"\/\/html5-player.libsyn.com\/embed\/episode\/id\/42581225\/height\/300\/theme\/custom\/thumbnail\/yes\/direction\/forward\/render-playlist\/no\/custom-color\/88AA3C\/\" height=\"300\" width=\"600\" scrolling=\"no\"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen><\/iframe>","thumbnail_url":"https:\/\/assets.libsyn.com\/secure\/content\/205516775"}